Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShanghai 10th People's Hospital

About this trial

To explore whether a ReDS-guided strategy for AMI patients with cardiac insufficiency following coronary flow reperfusion is superior to routine care for improving outcomes.

Eligibility criteria

Qualifiers

Patients were required to be aged ≥ 18 years and to be hospitalized for a primary diagnosis of AMI,

AMI patients accompanied by cardiac insufficiency following coronary revascularization, which is characterized by the symptoms and signs of fluid overload, regardless of left ventricular ejection fraction (LVEF), and have an N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration of ≥ 400 pg/L or a BNP concentration of ≥ 100 pg/L.

Disqualifiers

Patient's physical characteristics that prevented the use of the ReDS system (height of <155 or >190 cm; body mass index of <22 or >39 kg/m2)

Patients with chronic obstructive pulmonary disease or other lung diseases that might confound ReDS values

Patients with a left ventricular assist device or undergoing cardiac transplantation;

Patients with congenital heart malformations or intrathoracic mass that would affect right lung anatomy;

Trial design

Treatments tested in this trial

  • Remote dielectric sensing system

Treatment groups

2,000 Participants
are divided into 2 treatment groups